Adobe (NASDAQ:ADBE) reported quarterly earnings of $3.03 per share which beat the analyst consensus estimate of $2.81 by 7.83 percent. This is a 23.67 percent increase over earnings of $2.45 per share from the same
Biogen Inc. (NASDAQ:BIIB) today announced topline results from its Phase 2 TANGO study of gosuranemab (BIIB092), an investigational anti-tau antibody that was being evaluated as a potential treatment for
Oracle (NYSE:ORCL) reported quarterly earnings of $1.54 per share which beat the analyst consensus estimate of $1.31 by 17.56 percent. This is a 28.33 percent increase over earnings of $1.20 per share from the same